baber/WOPTO huggingface dataset:
Patent NZ-304146-A (NZ)
Title: Back pedal brake for chain driven vehicles, unidirectional clutch on pedal crank axle attached to brake cables
Inventor: PHILLIPS JONATHON
IPC: B62L5/18
Filed: 1996-03-15
Abstract: pedal crank assembly for a chain driven vehicle includes a unidirectional clutch to which a housing is attached.  During forward motion of the crank axle, the clutch housing is stationary.   An extension 14 of the housing is attached to a brake actuator 31, which is attached to brake cable 23. The brakes are applied by reverse rotation of the crank assembly which causes the clutch housing to rotate with the crank axle.   This causes the extension 14 to pull on brake actuator 31, which pulls the brake cable 23, applying the brakes. The arrangement allows different braking forces to be applied to the front and rear brakes.
Patent NZ-325197-A (NZ)
Title: A piece of cloth for decorating a roller blind, a kit of such pieces and a roller blind
Inventor: MOLLER BRENT
IPC: E06B9/24
Filed: 1996-12-16
Abstract: The roller blind is for use in connection with roof windows mounted in pitched roofs and comprises a preferably spring-loaded roller tube (1) which is mountable at the top of the frame or sash structure of the window and a flexible roller blind cloth (2) rolled up thereon as well as means for retaining the roller blind cloth (2) when rolled out against the spring-load on the roller tube (1) at least in a fully rolled-out condition of the roller blind cloth (2), in which the roller blind cloth (2) in at least a comparatively narrow, ribbon-shaped zone (4) in parallel with the roller tuber (1) is designed for fastening an edge portion of an additional cloth (3) of flexible material, such that the additional cloth (3) when the roller blind cloth (2) is rolled out, will hang freely down therefrom and when the roller blind is rolled up follow the roller blind cloth (2) during its rolling up on the roller tube (1).
Patent NZ-329345-A (NZ)
Title: Adjacent sheets of large tents or marquees interconnected by two uprights on support to engage respective sheet eyelets with tensioning plate located over sheets and uprights
Inventor: BURNETT GRAEME
IPC: E04H15/00
Filed: 1998-12-01
Abstract: heet eyelets 14 are located over respective uprights 3 attached to support structure 2.  Tensioning plate 5 is located over eyelets 14 and uprights 3.
Patent NZ-330383-A (NZ)
Title: Shower or other wash unit with support to hold replaceable brush or pad
Inventor: POATA TAMA TE KAPUA
IPC: A47K7/02
Filed: 1998-05-07
Abstract: A holder for a washing device for use in a shower consists of a holder 1, which holds a brush or a sponge, so that a user can rub against it, for example, to wash the user's back.  The holder is mounted on one or more walls of a shower cabinet with arms 3 and 4 being attached to the cabinet walls.  The holder includes channels into which complementary projections on a washing device can fit.  The washing device may be attached to a mounting plate, which has the projections.  The construction of the holder allows the washing device to be readily removed for cleaning or replacement.
Patent NZ-337977-A (NZ)
Title: Broadband coaxial surge arrester
Inventor: KUHNE GREGOR
IPC: H01P1/202
Filed: 1999-02-12
Abstract: A broad-band EMP surge arrester in a coaxial line with a waveguide positioned in an outer conductor and electrically connected to the inner conductor of the coaxial line by a short-circuit line (24), wherein sections of conductor (31, 32, 33, 34, 35) exhibiting differing wave impedance are built into the inner conductor of the coaxial line and determine the band width of the frequency band to be transmitted.  The band width may be adjusted during manufacture up to more than an octave.
Patent NZ-500783-A (NZ)
Title: Assessing deep muscle function on basis of superficial muscle activity
Inventor: JULL GWENDEON ANNE
IPC: A61B5/00
Filed: 1998-05-08
Abstract: To assess the function of deep joint stabilizing muscles, superficial muscles are monitored using an EMG (3) during performance of an activity known to require recruitment, primarily, of deep stabilizing muscles when performed correctly. If the deep muscle functions adequately, there is little activity of the superficial muscles. Conversely, if the deep muscle function is inadequate, the superficial muscle activity is increased. Monitoring of the superficial muscles may be combined with monitoring of the deep joint stabilizing muscle using ultrasound imaging (12) and/or pressure biofeedback. A suitable apparatus includes an EMG unit (3) ultrasound unit, and a pressure biofeedback unit (16) in combination with a computer (5) to give an indication of function.
Patent NZ-504190-A (NZ)
Title: Shaped implants in human medicine made from polyurethanes with ester links that are small enough to be hydrolysed and reabsorbed by the human body
Inventor: FLODIN PER
IPC: A61L31/06
Filed: 1998-10-19
Abstract: Shaped bodies for use as implants in human and veterinary medicine as pins, screws, discs, ligament fixtures and the like. The shaped bodies consist of polyurethanes having ester links which can be hydrolysed in a human body and which give hydrolysis fragments which are sufficiently small to be reabsorbed in the human body. The shaped bodies are characterised in that the polymer is a network polymer which substantially lacks urea groups. Also described is a method for the production of the shaped bodies which means that a suitable starting mixture according to the invention is introduced in moulds and cured at a temperature of 70-150°C in the absence of catalysts and at a temperature of 30-100°C in the presence of a catalyst.
Patent NZ-504776-A (NZ)
Title: Imidazonaphthyridines and their use in inducing cytokine biosynthesis
Inventor: LINDSTROM KYLE JON
IPC: A61K31/4745
Filed: 1998-12-11
Abstract: A compound of the formula I, or a pharmaceutically acceptable salt thereof, wherein: A is =N-CR=CR-CR=; =CR-N=CR-CR=; =CR-CR=N-CR=; or =CR-CR=CR-N=; R1 is selected from the group consisting of hydrogen, alkyl or alkenyl that is unsubstituted or substituted by one or more substituents selected from the group consisting of aryl, heteroaryl, heterocyclyl, alkyl,-O-(alkyl)0-1-aryl, -O-(alkyl)0-1-heteroaryl, -O-(alkyl)0-1-heterocyclyl, alkoxycarbonyl, -S(O)0-2-alkyl, -S(O)0-2-(alkyl)0-1-aryl, -S(O)0-2(alkyl)0-1-heteroaryl, -S(O)0-2-(alkyl)0-1-heterocyclyl, -N(R3)2, -N3, oxo, halogen, -NO2, -OH and -SH; alkyl-NR3-Q-X-R4 or alkenyl-NR3-Q-X-R4; Q is-CO-or SO2-; X is a bond, -O- or -NR3-; R4 is aryl; heteroaryl; heterocyclyl; or alkyl or alkenyl that is unsubstituted or substituted by one or more substituents selected from the group consisting of aryl, heteroaryl, heterocyclyl, O-alkyl, -O-(alkyl)0-1-aryl, -O-(alkyl)0-1-heteroaryl, -O-(alkyl)0-1-heterocyclyl, -alkoxycarbonyl, -S(O)0-2-alkyl, -S(O)0-2-(alkyl)0-1-aryl, -S(O)0-2-(alkyl)0-1-heteroaryl, -S(O)0-2-(alkyl)0-1-heterocyclyl, -N(R3)2; -NR3-CO-O-alkyl, -N3, oxo, halogen, -NO2, -OH, and -SH; or R4 is a group of formula (Ia) wherein Y is -N-or -CR-; R2 is selected from the group consisting of -hydrogen; -alkyl;  -alkenyl; -aryl; -alkyl-O-alkyl; -alkyl-O-alkenyl; and -alkyl or alkenyl substituted by one or more substituents selected from the group consisting of -OH, -halogen, -N(R3)2, -CO-N(R3)2, -CO-alkyl, -N3, -aryl, -heteroaryl, -heterocyclyl, -CO-aryl and -CO-heteroaryl; each R3 is independently selected from the group consisting of hydrogen and alkyl; and each R is independently selected from the group consisting of hydrogen, alkyl, alkoxy, halogen and trifluoromethyl. A compound of the formula II or a pharmaceutically acceptable salt thereof, wherein B is -NR-C(R)2-C(R)2-C(R)2-, -C(R)2-NR-C(R)2-(R)2-, -C(R)2-C(R)2-NR-C(R)2- or -C(R)2-C(R)2-C(R)2-NR- and R and R1 are as defined in formula (I). A compound of formula (III) or a pharmaceutically acceptable salt thereof, wherein A is -N=CR-CR=CR-, -CR=N-CR=CR-, -CR=CR-N=CR- or -CR=CR-CR=N-, and R and R1 are as defined in formula (I). Compounds of formulae (XXXIII) and (XXXIV) or pharmaceutically acceptable salts thereof, wherein R and R1 are as defined in formula (I). A compound of formula (IV) or a pharmaceutically acceptable salt, wherein A is =N-CR=CR-CR=, =CR-N=CR-CR=, =CR-CR=N-CR=, or =CR-CR=CR-N=, R7 is OH, halogen, or NHR1, R and R1 are as defined in formula (I) and R8 is H, N02 or NH2; A compound of formula (V) or pharmaceutically acceptable salts thereof, wherein A is =N-CR=CR-CR=, =CR-N=CR-CR=, =CR-CR=N-CR=, or =CR-CR=CR-N= and R9 is H or alkyl. A compound of formula (XXXII) or a pharmaceutically acceptable salt thereof, wherein R and R1 are as defined in formula (I) and R10 is-N02 or NH2. Compounds of formulae (I) and (II) are useful for inducing cytokine synthesis and treating viral infections.
Patent NZ-508845-A (NZ)
Title: Method for preparing pharmaceutically valuable norbenzomorphane derivatives
Inventor: BALTES HANFRIED
IPC: C07D221/22
Filed: 1999-05-07
Abstract: A process for preparing R- or S-norbenzomorphanes of Formula 1 comprises a 4-methylene-piperidine derivative of Formula 2 is converted with an acid into the corresponding acid addition salt. The salt is then reacted in a reaction medium with an aluminium (iii) halide at a temperature in the range from 0 to 150oC. After the reaction is completed the reaction product is isolated. In Formula 1 and 2 R1 is H, C1-8 alkyl, C1-8 alkoxy, hydroxy or halogen
Patent NZ-509760-A (NZ)
Title: Method and apparatus for secure communication of information between a plurality of digital audiovisual devices
Inventor: DAUVOIS JEAN-LUE
IPC: H04L29/06
Filed: 1999-07-14
Abstract: A method of providing secure communication of information between at least a first and second digital audiovisual device (30, 52) and characterised in that the first device (30) communicates to the second device (52) a certificate Ct(KpubT) comprising a transport public key KpubT encrypted by a management private key KpriMan, the second device (52) decrypting the certificate using an equivalent management public key KpubMan and thereafter using the transport public key KpubT to encrypt information sent to the first device, the first device using an equivalent private key KpriT to decrypt the information, is disclosed. It is particularly applicable to a method of providing secure communication between a first and second decoder.
Patent NZ-511851-A (NZ)
Title: Manufacture of reduced and low fat cheese where a mixture of rice grains and water is combined with a finished cheese product
Inventor: NELLES JAKOB
IPC: A23C19/00
Filed: 1998-12-03
Abstract: An apparatus and process for producing reduced and low-fat, high-quality pasta filata cheese incorporates a rice-based cheese substitute into freshly manufactured past filata cheese through a kneading, spraying process that preserves the integrity of the cheese's fibre structure. The rice based cheese substitute may be manufactured on-site with a heated double walled vessel equipped.
Patent NZ-512886-A (NZ)
Title: N-Piperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxamide
Inventor: CAMUS PHILIPPE
IPC: A61P25/28
Filed: 2000-01-28
Abstract: N-piperidino-5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxamide of formula I, its salts and solvates.  A process for preparing these compounds characterized in that a functional derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-3-carboxylic acid of formula II is reacted with 1-aminopiperidine with subsequent optional conversion to one of its salts or solvates.  These compounds are used for treating disease involving the cannabinoid CB1 receptors.
Patent NZ-519062-A (NZ)
Title: Peptides for treatment of erectile dysfunction
Inventor: ARGIOLAS ANTONIO
IPC: A61K38/095
Filed: 2000-11-04
Abstract: A peptide of the formula X-A-B-C-Y-NH2 wherein X is a- aminoisobutyryl, tranexamyl (i.e. 4-(aminomethyl cyclohexanecarbonyl, isonipecotinyl, g-aminobutyryl, hydrogen, or imidazolylacetyl, A is D-2-methyl-tryptophan, D-b-(2-naphthyl) alanine, or D-tryptophan; B is D-2-methyl- tryptophan, D-b-(2-naphthyl) alanine, D-tryptophan, or is absent, C is D-2-methyl-tryptophan, phenylalanine, or is absent and Y is lysine or arginine. D stands for the dextro isomer; or a pharmaceutically acceptable addition salt of the peptide can be used to cause penile erection or to treat erectile dysfunction. Also described is pharmaceutical composition salt comprising a peptide having the formula GAB-D-Mrp- D-bNal-Phe-Arg-NH2 or GAB-D-Mrp-DMrp- Lys-NH2 and pharmaceutically acceptable salts.
Patent NZ-523693-A (NZ)
Title: Macrolide formulations for inhalation and methods of treatment of endobronchial infections
Inventor: BAKER WILLIAM R
IPC: A61P31/04
Filed: 2001-07-01
Abstract: Macrolide formulations, such as an erythromycylamine formulation, for delivery by aerosolization are disclosed, wherein the concentrated erythromycylamine formulations contain an amount of erythromycylamine effective to treat pulmonary infections caused by susceptible bacteria. Unit dose devices having a container containing a formulation of the macrolide antibiotic in a physiologically acceptable carrier are also described. Methods for treatment of pulmonary infections by a formulation (liquid solution, suspension, or dry powder) delivered as an aerosol having mass median aerodynamic diameter predominantly between 1 to 5 mm are also described.
Patent NZ-525016-A (NZ)
Title: Isoxazoles and their use as inhibitors of ERK
Inventor: HALE MICHAEL
IPC: A61K31/42
Filed: 2001-09-14
Abstract: Disclosed herein are compounds of formula (I) that are useful as protein kinase inhibitors, especially inhibitors of ERK, wherein Ht is an optionally substituted heteroaryl ring selected from pyrrol-3-yl, pyrazol-3-yl, [1,2,3]triazol-4-yl, [1,2,4]triazol-3-yl, or tetrazol-5-yl, and A-B is N-O or O-N, and wherein R1, R2 and T are as defined in the specification. These compounds are useful for treating diseases in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.
Patent NZ-525137-A (NZ)
Title: Improvements in phalloplasty
Inventor: MOORE COLIN CAMPBELL MARSHALL
IPC: A61B17/00
Filed: 2003-04-03
Abstract: A method of lengthening the penis of a male which includes the steps of placing the suspensory ligament under tension in the inferior direction; dividing the suspensory ligament against the body of the symphysis pubis down to the inferior pubic arch and along the inferior surface of both the right and left conjoined inferior pubic rami; effecting suturing to retain the penis released from the suspensory ligament in an inferior position by coapting the proximal medial attachments of the right and left gracilus muscle together ventral the released penis, dividing the fundiform ligaments, drawing the skin of the junction site of the scrotum and the perineum mediosuperiorially so as to attach it to the symphysis pubis thereby pushing the skin adjacent thereto along the newly exposed shaft of the penis and suturing this to retain this position.
Patent NZ-525661-A (NZ)
Title: Pharmaceutical dronedarone composition for parenteral administration comprising a buffer solution and a beta- cyclodextrin
Inventor: BOURRIAGUE-SEVE FREDERIQUE
IPC: A61P9/06
Filed: 2001-12-10
Abstract: A pharmaceutical composition for parenteral administration comprises dronedarone, a physiologically acceptable buffer solution capable of maintaining the pH of the composition between 3 and 5 and a physiologically acceptable water-soluble b-cyclodextrin derivative. Preferably the buffer solution is a system chosen from acetic acid/alkali metal acetate, fumaric acid/ alkali metal fumarate, succinic acid/alkali metal succinate, citric acid/alkali metal citrate, tartaric acid/alkali metal tartrate, lactic acid/alkali metal lactate, maleic acid/ alkali metal maleate, methansulphonic acid/ alkali metal methanesulphonate or monoalkali metal phosphate.
Patent NZ-528645-A (NZ)
Title: 5-membered heterocycles, preparation and application thereof as medicaments
Inventor: HARNETT JEREMIAH
IPC: A61K31/497
Filed: 2002-04-09
Abstract: Thiazole and imidazole derivatives are described. The compounds can be used in pharmaceutical compositions for inhibiting monoamine oxidases (MAO), particularly MAO B, inhibiting lipidic peroxidation, modulating activity via sodium channels and for treating Parkinson's disease, senile dementia, Alzheimer's disease, Huntington's, amyotrophic lateral sclerosis, schizophrenia, depression, psychoses, migraine and pain, particularly neuropathic pain.
Patent NZ-530321-A (NZ)
Title: Protective headgear
Inventor: PRIMROSE ROHAN
IPC: A42B1/04
Filed: 2002-07-10
Abstract: Disclosed is a shell for fitting within a headcap to provide a degree of protection from impacts, the shell being of a generally concave shape, and being formed with a pair of slots, one on each side of the shell, each slot opening into the back side of the shell and extending in a generally back to front direction towards the front of the shell so as to effectively divide the shell into different regions, together marking up the concave shape, a top region extending, when worn, back to front over the top of the head and merging into a front region which extends, when worn, across the front of the head and two lateral regions extending, when worn, back to front across respective sides of the head and merging into the front region, and wherein each slot separates a respective lateral region from the top region and is of a width sufficient to enable the respective lateral region to be flexed towards and away from the top region to thereby enable the size of the shell to be altered to accommodate a range of head sizes.
Patent NZ-532402-A (NZ)
Title: Iontophoresis device
Inventor: MATSUMURA AKIHIKO
IPC: A61N1/30
Filed: 2002-05-15
Abstract: An iontophoresis device for administering an ionic drug by iontophoresis has an iontophoresis electrode section (active electrode section) and a ground electrode section (inactive electrode section) both of which are connected to a power source. The iontophoresis electrode section (1) comprises: an electrode plate (11) connected to a power source of the same polarity as the charged ions of the ionic drug, an electrolyte-solution-retaining membrane (12) arranged on a front side of the electrode plate and retaining therein an electrolyte solution in such a state that the electrolyte-solution-retaining membrane is impregnated with the electrolyte solution, an ion exchange membrane (13) arranged on a front side of the electrolyte-solution-retaining membrane and selective to ions opposite in polarity to the charged ions of the ionic drug, an ionic-drug-retaining membrane (14) arranged on a front side of the ion exchange membrane and retaining therein the ionic drug in such a state that the ionic-drug-retaining membrane is impregnated with the ionic drug, and an ion-exchange membrane (15) arranged on a front side of the ionic-drug-retaining membrane and selective to ions of the same species as the charged ions of the ionic drug. The ground electrode section (2) comprises: an electrode plate (21) opposite in polarity to the electrode plate in the iontophoresis electrode section, an electrolyte-solution-retaining membrane (22) arranged on a front side of the electrode plate and retaining therein an electrolyte solution in such a state that the electrolyte-solution-retaining membrane is impregnated with the electrolyte solution, and an ion exchange membrane (23) arranged on a front side of the electrolyte-solution-retaining membrane and selective to ions opposite in polarity to the charged ions of the ionic drug.
Patent NZ-533990-A (NZ)
Title: Phenylalkyne compounds useful for the treatment of disorders and conditions modulated by a histamine receptor
Inventor: APODACA RICHARD
IPC: A61K31/4709
Filed: 2002-12-02
Abstract: A substituted phenylalkynes compound of Formula (I) is described. The compound can be used in the manufacture of a medicament for treatment of disorders and conditions modulated by a histamine receptor.
Patent NZ-540820-A (NZ)
Title: Vine support system
Inventor: MALINS CRAIG DAVID
Filed: 2005-06-17
Abstract: A system for supporting a wire, from a Y-post with at least one aperture, includes a bracket having a body extending laterally outwardly from either side of a slot. A number of wire-receiving means are disposed outwardly of the slot and orientated generally parallel to it. Fastener receiving means are also disposed either side of the slot. A fastener is also provided which is adapted to extend through the aperture in the post and engage the fastener receiving means.
Patent NZ-540976-A (NZ)
Title: Cathode systems for electrolytically obtaining aluminium
Inventor: BANEK MANFRED
Filed: 2003-12-18
Abstract: A cathode system for electrolytically obtaining aluminium is disclosed. The cathode system comprises carbon cathodes (1) and collectors (2). The cathode system is divided in the direction of its long axis on the side of the power conduction from the cathode to the collector into at least two parts. The at least two parts have a differing electrical resistance in such a way that the electrical resistance from the ends of the collector to the part of the cathode facing the collector at the ends of the cathode is at least 1.2 times the electrical resistance from the ends of the collector to the part of the middle of the length of cathode facing the collector. The division of the cathode system into at least two parts of differing electrical resistance is achieved by use of different contact compositions (13, 14) between collector and cathode and/or by dividing the collector in the direction of its long axis on the side of the power conduction to the cathode into at least two parts of differing electrical resistance.
Patent NZ-542357-A (NZ)
Title: Stereoscopic universal digital camera adapter
Inventor: RAMADAN SAMER
IPC: H04N13/221
Filed: 2004-02-13
Abstract: Apparatus for mounting a camera for taking stereoscopic photographs is disclosed. The camera is mounted on a mechanism for shifting the camera between left and right positions and software receives images taken from each position and tints them different colours for combination to form a single 3D image viewable with 3D glasses. The mounting mechanism may be one of three embodiments. The first includes a guiding track (3) for attachment to a tripod, the track having a recess with dead end stops and a slide plate (1) that slides within the recess. The camera is secured to the side plate with quick locking and releasing means. The second mounting mechanism has a flat base plate and a sliding guide slideably attached to the plate along a back ridge. Right and left end stops are spaced apart approximately the distance between a pair of human eyes. The third mounting mechanism has top, middle, and bottom plates in rotational communication with each other. The camera attaches to the top plate while the tripod attaches to the bottom plate. The middle plate rotates so that the camera lens points in the same direction at the left and right positions.
Patent NZ-546552-A (NZ)
Title: A method for increasing CD8+ cytotoxic T cell reponses and for treating multiple sclerosis
Inventor: ZANG YING
IPC: A61K39/00
Filed: 2004-10-18
Abstract: Provided is a method of making an autologous T cell vaccine for the treatment of multiple sclerosis comprising: (a) reducing a population of patient peripheral blood mononuclear cells comprising CD4+ T cells; (b) adding a MS associated antigen and optionally antigen presenting cells; and (c) repeating step (b) one or more times. Further provided are vaccines produced by the method and use of the vaccine in the manufacture of a medicament for treating multiple sclerosis.